SCHEMBL19322686

SCHEMBL19322686

O=C(/C=C/C1CCCCCCC1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 3/20 0.50
GRIN1 Q05586 1/20 0.48
GRIN2B Q13224 1/20 0.48
MAPT P10636 4/20 0.47
RECQL P46063 2/20 0.47
PLIN1 O60240 2/20 0.47
LMNA P02545 2/20 0.47
PLIN5 Q00G26 2/20 0.47
ABHD5 Q8WTS1 2/20 0.47
MAOB P27338 2/20 0.47
BCHE P06276 1/20 0.47
TNFRSF1A P19438 1/20 0.47
ACHE P22303 1/20 0.47
CYP1B1 Q16678 1/20 0.47
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 4/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
NFKB1 P19838 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5194748 1.00 PADI4 (0.50) PADI4GRIN1GRIN2BMAPTRECQL
SCHEMBL5194755 1.00 PADI4 (0.50) PADI4GRIN1GRIN2BMAPTRECQL
SCHEMBL22272411 0.95 PADI4 (0.49) PADI4GRIN1GRIN2BMAPTRECQL
SCHEMBL17064498 0.91 MAPT (0.52) PADI4MAPTRECQLPLIN1LMNA
SCHEMBL17064497 0.91 MAPT (0.52) PADI4MAPTRECQLPLIN1LMNA
SCHEMBL7242364 0.82 CHRNA7 (0.49) MAPTALDH1A1MAPK1NFKB1NFKB2
SCHEMBL7242365 0.82 CHRNA7 (0.49) MAPTALDH1A1MAPK1NFKB1NFKB2
SCHEMBL4149871 0.80 ACHE (0.44) PADI4MAPTRECQLPLIN1LMNA
SCHEMBL4149874 0.80 ACHE (0.44) PADI4MAPTRECQLPLIN1LMNA
SCHEMBL7488747 0.79 ALDH1A1 (0.48) MAPTRECQLPLIN1LMNAPLIN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170253583-A1 HETEROAROMATIC CHALCONE DERIVATIVES AND THEIR MEDICAL USE Universität Wien (AT) 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253583-A1 HETEROAROMATIC CHALCONE DERIVATIVES AND THEIR MEDICAL USE CYP2E1, CYP3A43, CYP11B1 PADI4 4850/4885GRIN1 4740/4885GRIN2B 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.